© Pint of Science, 2024. All rights reserved.
Cancer affects 1 in 2 people during their lifetimes and claims millions of lives across the world. Current therapies include chemotherapy, radiotherapy and surgery, however, more effective and specific treatments are needed. Join researchers from the Norfolk-based cancer charity 'Big C' for an inspiring insight into the cutting edge of our fight against cancer! Scientists will take attendees on a journey inside the cell, explaining the processes which drive the development of cancer and sharing their efforts in the race to develop new, effective anti-cancer therapies.
Jekyll and Hyde: Two personalities of Sulforaphane in Cancer prevention and treatment
Julia Mundy
(PhD student at the University of East Anglia )
During their lifetime 1 in 2 individuals will be affected by cancer. Diets rich in broccoli have been linked to reduced risk of many cancer types, thanks to one particular component: sulforaphane. The Jekyll and Hyde character of sulforaphane allows it to protect the body by preventing cancer from forming and also kill established cancer cells. The talk will explore some of these effects, including those effecting the internal supportive structure within cells known as the cytoskeleton, and the potential of sulforaphane as a new anti-cancer drug.
Reprogramming Cancer Cells Back to Normal
Dr Darrell Green
(Researcher of Molecular Biology at The University of East Anglia )
DNA and RNA are the genetic material carrying the instructions used in our development, functioning and reproduction. RNA plays a vital role in controlling when and where particular genes are expressed. Darrell, who’s PhD was funded by Big C, will discuss how cancer manipulates its use of RNA for its own benefit. By reprogramming the RNA within cancer, Darrell’s research has shown the potential of a new type of cancer treatment
Map data © OpenStreetMap contributors.